ImmunoCyt a useful method in the follow-up protocol for patients with urinary bladder carcinoma

Scand J Urol Nephrol. 2001 Sep;35(4):280-2. doi: 10.1080/003655901750425846.

Abstract

Objective: To evaluate the ImmunoCyt test--a urine-bound test for the detection of malignant transitional cells.

Patients and methods: ImmunoCyt was compared with the standard investigation at our hospital for bladder cancer--cystoscopy, cytological examination of bladder wash material and, if necessary, a histological examination. A voided urine sample was collected before cystoscopy. We investigated 121 patients; seven specimens could not be evaluated.

Results: Thirty-one of the 114 patients had a histologically proven urinary bladder carcinoma. All 31 cases were positive in the ImmunoCyt test. Twenty-six of the 83 negative cases were ImmunoCyt positive. The sensitivity was 100% and the specificity was 68.7%.

Conclusion: ImmunoCyt is easily applicable in a small laboratory and has high sensitivity and acceptable specificity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal
  • Antigens, Neoplasm / analysis
  • Carcinoembryonic Antigen / analysis
  • Carcinoma, Transitional Cell / diagnosis*
  • Carcinoma, Transitional Cell / urine
  • Cystoscopy
  • Female
  • Humans
  • Immunohistochemistry / methods*
  • Male
  • Middle Aged
  • Mucins / analysis
  • Prospective Studies
  • Sensitivity and Specificity
  • Urinary Bladder Neoplasms / diagnosis*
  • Urinary Bladder Neoplasms / urine
  • Urine / cytology

Substances

  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Carcinoembryonic Antigen
  • Mucins